Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Burmester, Gerd R, Prof, Blanco, Ricardo, MD, Charles-Schoeman, Christina, MD, Wollenhaupt, Jürgen, Prof, Zerbini, Cristiano, MD, Benda, Birgitta, MD, Gruben, David, PhD, Wallenstein, Gene, PhD, Krishnaswami, Sriram, PhD, Zwillich, Samuel H, MD, Koncz, Tamas, MD, Soma, Koshika, MD, Bradley, John, MD, Mebus, Charles, PhD
Published in The Lancet (British edition) (09.02.2013)
Published in The Lancet (British edition) (09.02.2013)
Get full text
Journal Article
Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis
Vieira, Maria-Cecilia, PhD, Zwillich, Samuel H., MD, Jansen, Jeroen P., PhD, Smiechowski, Brielan, MSc, Spurden, Dean, PhD, Wallenstein, Gene V., MD
Published in Clinical therapeutics (01.12.2016)
Published in Clinical therapeutics (01.12.2016)
Get full text
Journal Article